瘤内血栓形成作为预测胶质母细胞瘤患者表皮生长因子受体改变及不良预后的组织学生物标志物
该研究对97例胶质母细胞瘤组织标本进行临床病理与遗传学分析,探讨血栓事件及相关分子异常的作用。结果显示,瘤内血栓形成与女性、术前D-二聚体水平高及EGFR扩增显著相关,且为独立的不良预后因素;20个高倍视野内存在1个或以上血栓是EGFR扩增的预测标志,敏感度81.5%、特异度52.6%。
要点
- 瘤内血栓形成与女性、术前D-二聚体水平高及EGFR扩增显著相关。
- 20个高倍视野内≥1个血栓预测EGFR扩增的敏感度81.5%、特异度52.6%。
- 瘤内血栓形成是独立的不良预后因素。
核心结论
- 异常的但受到精细调控的EGFR可诱导肿瘤浸润区域非微血管增生血管内血栓形成,继而促进栅栏状坏死,随后出现缺氧、异常血管生成和进一步的肿瘤细胞浸润。
研究设计与样本
- 对97例胶质母细胞瘤组织标本进行临床病理与遗传学分析,以阐明血栓事件及相关分子异常的作用。
主要发现
- 形态学上,瘤内血栓形成在肿瘤周边由单层CD34阳性内皮和/或αSMA阳性周细胞构成的血管中,比肿瘤中心多通道、周细胞增生的微血管增生血管中更常见。
- 瘤内血栓形成与女性、术前D-二聚体水平高及表皮生长因子受体(EGFR)扩增显著相关。
- 20个高倍视野内存在1个或以上血栓是EGFR扩增的预测标志,敏感度81.5%、特异度52.6%。
- RNA测序显示,血栓多的组EGFR基因表达水平高于血栓少的组。
- 肿瘤周边沿血管浸润的肿瘤细胞为野生型EGFR阳性、EGFRvIII阴性,而肿瘤中心微血管增生(MVP)周围的细胞为野生型EGFR和EGFRvIII均阳性。
关键数值与推荐
- 20个高倍视野内存在1个或以上血栓预测EGFR扩增的敏感度81.5%、特异度52.6%。
临床怎么用
- 作者认为,异常的但受到精细调控的EGFR可诱导肿瘤浸润区域非MVP血管内血栓形成,继而促进栅栏状坏死,随后出现缺氧、异常血管生成和进一步的肿瘤细胞浸润。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Intratumoral thrombosis is a specific finding in glioblastomas and considered the origin of palisading necrosis. Its distribution and contribution to the glioblastoma pathophysiology and systemic thrombosis are obscure, although deep vein thrombosis is a common complication in glioblastoma cases. METHODS: Clinicopathological and genetic analyses were performed on 97 glioblastoma tissue specimens to elucidate the role of thrombotic events and associated molecular abnormalities. RESULTS: Morphologically, intratumoral thrombosis was observed more frequently in vessels composed of single-layered CD34-positive endothelium and/or αSMA-positive pericytes in the tumor periphery, compared to microvascular proliferation with multi-channeled and pericyte-proliferating vessels in the tumor center. Intratumoral thrombosis was significantly correlated with the female sex, high preoperative D-dimer levels, and epidermal growth factor receptor (EGFR) amplification. The presence of one or more thrombi in 20 high-power fields was a predictive marker of EGFR amplification, with a sensitivity of 81.5% and specificity of 52.6%. RNA sequencing demonstrated that the group with many thrombi had higher EGFR gene expression levels than the group with few thrombi. The tumor cells invading along the vessels in the tumor periphery were positive for wild-type EGFR but negative for EGFRvIII, whereas the cells around the microvascular proliferation (MVP) in the tumor center were positive for both wild-type EGFR and EGFRvIII. Intratumoral thrombosis is an independent poor prognostic factor. CONCLUSIONS: Aberrant but exquisitely regulated EGFR can induce thrombosis in non-MVP vessels in the tumor invasion area and then promote palisading necrosis, followed by hypoxia, abnormal angiogenesis, and further tumor cell invasion.
引用
- Furuta T, Negoto T, Miyoshi H, et al. Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas. J Neurooncol. 2023. PMID: 37710025. doi:10.1007/s11060-023-04447-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。